GAL-FR-21

N/A

Report date: 2022/06/07 15:14:31

Base Information

Drug NameGAL-FR-21

Drug Alias NameGAL-FR-21GAL-FR21HuGAL-FR21

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionFibroblast growth factor receptor 2 antagonists

TargetsFibroblast growth factor receptor 2

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGalaxy Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGalaxy Biotech

Active IndicationsN/A

Inactive IndicationsStomach Neoplasms

ATC CodeN/A